Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery

article

Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S41512-019-0048-7
P932PMC publication ID6460751
P698PubMed publication ID31093573

P50authorDavid L BrownQ91304965
P2093author name stringEric Novak
Ronald Krone
Andrew Perry
Matthew J Chung
P2860cites workStrategies for multivessel revascularization in patients with diabetesQ28278561
Presentation of multivariate data for clinical use: The Framingham Study risk score functionsQ30927826
Multiple imputation: a primerQ33646777
A randomized trial of therapies for type 2 diabetes and coronary artery diseaseQ33827504
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialQ33923921
Appropriate revascularization in stable angina: lessons from the BARI 2D trialQ34696317
The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studiesQ35025208
Coronary-artery bypass surgery in patients with left ventricular dysfunctionQ36152222
Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trialsQ36353650
Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trialQ36762868
Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community EquipoiseQ38652030
Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgeryQ46218908
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery diseaseQ46820470
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary SyndromesQ47309068
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinQ56040237
2013 ESC guidelines on the management of stable coronary artery diseaseQ57243329
Hypotheses, Design, and Methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) TrialQ61819895
A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fractionQ69868664
Multiple imputation of missing blood pressure covariates in survival analysisQ77327572
Influence of diabetes mellitus on early and late outcome after coronary artery bypass graftingQ77730221
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcoronary artery bypass surgeryQ186020
coronary artery diseaseQ844935
type 2 diabetesQ3025883
P304page(s)3
P577publication date2019-02-14
P1433published inDiagnostic and Prognostic ResearchQ68092009
P1476titleDevelopment of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery
P478volume3

Reverse relations

Q92946217Echocardiographic Changes in Newly Diagnosed Type 2 Diabetes Mellitus Patients with and without Hypertensioncites workP2860

Search more.